Clinical Study Shows Fluorescent Dye Can Localize Tumors During Surgery in Real-time
An experimental cancer imaging tool that makes tumors glow brightly during surgery has shown promise again in a new Penn Medicine clinical study, this time in patients with brain cancer. The fluorescent dye technique, originally developed by surgeons at the Penn Center for Precision Surgery to treat lung cancer, illuminated brain tumors in real-time during surgery, helping physicians distinguish between healthy and cancerous tissue. Each year, over 15,000 people in the United States undergo surgeries to remove brain tumors.
Findings from the pilot study, led by first author John Y.K. Lee, MD, MSCE, an associate professor of Neurosurgery in the Perelman School of Medicine at the University of Pennsylvania, and co-director of the Center for Precision Surgery, were reported in this week in Neurosurgery.
A big challenge with brain surgery is ensuring the entire tumor is removed. It is difficult to identify the margins of the tumor with current approaches. Cancer tissue not visible to the naked eye or felt by fingers is often missed during tumor removal, leading to recurrence in some patients – about 20 to 50 percent.
Penn’s approach, which relies on an injectable dye that accumulates in cancerous tissues more so than normal tissues, may help change that.
“Fluorescent contrast agents take visualization to a whole new level,” Lee said. “It has the potential for real-time imaging, identification of disease, and most importantly, precise detection of the tumor’s margins. With this, we know better where to cut.”
The study also includes co-author, Sunil Singhal, MD, an associate professor of Surgery, and co-director the Center for Precision Surgery at Penn’s Abramson Cancer Center, who first started work on this approach in his lab nearly 10 years ago.
The technique uses near-infrared, or NIR, imaging and the contrasting agent indocyanine green (ICG), which fluoresces a bright green under NIR light. ICG was developed during World War II as a dye in photography and, in 1958, it was approved by the U.S. Food and Drug Administration (FDA) for use in medicine, primarily in liver diagnostics and later in cardiology.
However, for this study, researchers used a modified version of ICG at a higher concentration delivered intravenously about 24 hours before surgery to ensure margins were included. This is the first time, to the authors knowledge, that this delayed imaging of ICG has been used to visualize brain tumors.
Patients enrolled in the clinical study were between the ages of 20 and 81 with a diagnosis of a solitary brain tumor and a presumed glioma based on imaging or prior surgery or biopsy.
Twelve of the 15 tumors demonstrated strong intraoperative fluorescence. The lack of glow in the three remaining tumors could potentially be due to their disease grade and timing of the injection, the authors suggested.
Eight of the 15 patients demonstrated a visible glow through the dura, a thick membrane on the meninges of the brain, was opened, demonstrating the technology’s ability to see deeply within the brain before the tumor is exposed. Once opened, all tumors were picked up by NIR imaging.
The researchers also studied the surgical margins using neuropathology and magnetic resonance imaging, (MRI) to assess the accuracy and precision of NIR fluorescence in identifying tumor tissue.
Of the 71 specimens collected from MRI-enhanced tumors and their surgical margins, 61 (85.9 percent) fluoresced and 51 of these (71.8 percent) were classified as glioma tissue.
Of the 12 MRI-enhancing gliomas, four patients had biopsy specimens that were both non-fluorescent and negative for tumor, which matched the gross total resection seen on their MRI. In contrast, 8 patients had residual fluorescent signal in the resection cavity. Only 3 of these patients showed gross total resection on MRI. This suggests a benefit of true-negative NIR signal after resection, the authors said.
Over the past three plus years, Singhal, Lee, and their colleagues have performed more than 300 surgeries with the imaging tool in patients with various types of cancer, including lung, brain, bladder and breast.
“This technique, if approved by the FDA, may offer great promise to physicians and patients,” Singhal said. “It’s a strategy that could allow greater precision across many different cancer types, help with early detection, and hopefully better treatment success.”
The Latest on: Glowing Tumor Technology
via Google News
The Latest on: Glowing Tumor Technology
- Violinist and brain surgeon reunite after he removed her tumour without destroying talenton February 28, 2020 at 2:15 pm
‘But medical advances and new technology mean we can now do the most amazing things ... Before surgery, patients drink the fluid, which makes aggressive cancer cells glow bright pink under blue ...
- 10 top brands that will improve your homeon February 28, 2020 at 8:40 am
If that wasn't enough reasons to pick up a pink design, SEBO are giving 25 percent of profits of the X7 Pastel Pink cleaner to The Pink Ribbon Foundation in support of those affected by breast cancer.
- The 13 Best Sunscreens to Shield Every Skin Typeon February 28, 2020 at 8:01 am
This Lancaster Sun formula contains Tan Activator Complex to give you a golden glow, while also protecting from infrared rays, another cause of skin cancer. This Kiehl’s sunscreen has an easy-to-apply ...
- Purdue ‘Light Up’ Cancer Technology Nears Commercializationon February 27, 2020 at 11:54 am
WEST LAFAYETTE - Company leaders believe these glowing guideposts will bring more certainty to the treatment of a disease that is notoriously elusive. The recently announced Phase 2 clinical trial ...
- Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNAon February 20, 2020 at 3:35 am
Multiple primary and cancer cell lines were utilized to verify the robustness of our data and to prevent any false positives due to misidentified cell lines listed in The ICLAC Register of ...
- New Technology Sheds Light On Bladder Canceron February 17, 2020 at 5:34 pm
An imaging solution, injected into the bladder, is absorbed by cancerous tissue. Using blue light, the tumors glow pink making them more visible and defined. Carol had 16 tumors removed. “If we didn’t ...
- Virtual idols, anime and a rock 'n' roll spirit: Nakamura Shido II leads kabuki's evolutionon February 15, 2020 at 3:27 am
The audience, most of whom are in their 20s and 30s, wave glow sticks and holler as the lights go down for the start of the show ... “Cho Kabuki” makes extensive use of cutting-edge technology to ...
- App that detects signs of eye diseases credited for preventing further vision loss for young boyon February 12, 2020 at 8:08 am
"I'd remember seeing some kind of news article or news report about a little boy having cancer in his eye, and it was caught by a glow in the eye like that ... there's nothing like seeing your ...
- Illuminating cancer surgery with a dye that makes tumors glowon February 9, 2020 at 11:10 pm
and immediate tumor margin assessment during surgery for adenocarcinomas of the lung were significantly improved with the use of this technology,” said Sarkaria, who also serves as vice chairman ...
via Bing News